Navigation Links
Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
Date:10/19/2009

is a welcome addition to the team at Peregrine, joining at an opportune time as we have just recently completed enrollment in all three of our ongoing bavituximab Phase II cancer trials, as well as a bavituximab Phase I cancer trial. He brings a tremendous amount of enthusiasm and experience across many different areas that will be very valuable as we continue to advance our clinical and preclinical programs."

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
2. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
3. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
4. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
5. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
6. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
7. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
8. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
9. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/pph6hl/united_states ... "United States Medical Adhesives Market Forecast and Opportunities, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The market ... States is projected to register 9% ... manufacturers across the US are expanding their production ...
(Date:5/28/2015)... May 28, 2015 The Parenteral Drug ... a supporting organization of the Johnson & Johnson ... 2016. Johnson & Johnson (J&J) is ... superbug infections in endoscopes. J&J ran 8 conferences ... 1976 and 2003 on advances in sterilization and ...
(Date:5/28/2015)... Calif. , May 28, 2015 Compassion & ... Committee has approved a bill that would authorize the option ... vote was 5-2. ... (SB 128) , would allow mentally competent adults with six ... medication they could take to painlessly and peacefully end an ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3
... Austria, October 20 AFFiRiS AG today announced,that the ... clinical studies of,its two Alzheimer,s vaccines AD01 and AD02, ... a 10 million EUR,milestone payment from licensee GlaxoSmithKline Biologicals. ... in these studies were given four vaccinations,which were well ...
... Oct. 20 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc.,(Nasdaq: YONG ... distributor of Shengmingsu brand plant and animal nutrient products ... the Company consummated,the restructuring plan required by its September ... Yongye is now a fully integrated manufacturer ...
Cached Medicine Technology:AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment 2AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment 3Yongye International Announces Completion of Restructuring 2Yongye International Announces Completion of Restructuring 3
(Date:5/28/2015)... NY (PRWEB) May 28, 2015 The ... Care are proud to present Dr. Alicia Almendral as ... be a big part of the newly opened facility’s ... finest in modern cosmetic treatments. , Dr. Almendral is ... in the latest anti-aging and cosmetic enhancement techniques. Her ...
(Date:5/28/2015)... Los Angeles, Calif. (PRWEB) May 28, 2015 ... announces its selection by ContentChecked (CNCK) as its ... ContentChecked’s latest health and nutrition app, SugarChecked. SugarChecked ... consumers to better understand the potential sugars they ... be responsible for the launch of SugarChecked, execute ...
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... 2015 Park Cities Pet Sitter is offering ... class starting Saturday, June 6th at 10:30am. The ... McCommas Blvd in Dallas, with a maximum of six dogs ... five weeks, with no class being held over the 4th ... , In this Intermediate-to-Advanced level class, dogs will solidify their ...
(Date:5/28/2015)... 28, 2015 The Boys & Girls Club ... Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... the club can receive much more support as play begins ... A former Boys & Girls Club member and volunteer with ... Ms. Gulbis has accepted the Horizon Blue Cross Blue Shield ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... Healthy City has raised concern over the high prevalence ... specially females, lower socio-economic and indigenous groups.//,Smoking, which still ... has the dubious distinction of affecting all the systems ... the Shanghai Municipal Center for Disease Prevention and Control ...
... artificial sweeteners got an impetus when a new study ... rat study conducted by Italy’s Ramazzini Institute //is totally ... conducted on aspartame. The U.S. Food & Drug Administration ... in the use of aspartame. The study, to be ...
... that the company is conducting various studies to start producing ... is high worldwide which may lead to a high shortage ... South Africa. ,The South African authorities feel that ... the maximum worldwide production of bird flu vaccines would be ...
... the UK after a successful bypass surgery in Delhi at ... medical tourism.// ,Mavis Childs, 67, waited for more than ... Service (NHS). But she opted for India when the operation ... pain., ,Childs, based in Wombourne, near Wolverhampton, says she ...
... issue of the Journal of the American Geriatrics Society, ... their incidence of falls if they take a vitamin ... vitamin D supplementation can reduce the incidence of falls ... are not classically vitamin D deficient, the Australian researchers ...
... this week’s Australian Medical Journal (AMA) has found that first-time ... of complications if they choose to deliver naturally in subsequent ... The study has found women who have a ... uterine ruptures during birth, post-partum bleeding, infection and hysterectomies than ...
Cached Medicine News:Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3Health News:British Grandmother has timely bypass surgery in India 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: